Erratum: The Pivotal Role of Integrin b1 in Metastasis of Head and Neck Squamous Cell Carcinoma (Clinical Cancer Research (2012) 18 (4589–4599) DOI: 10.1158/1078-0432.CCR-11-3127);The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma

Clinical Cancer Research

Volumn 18, Issue 17, 2012, Pages 4589-4599

  Wang, Dongsheng ^a   Müller, Susan ^a   Amin, A R M Ruhul ^a   Huang, Donghai ^a   Su, Ling ^a   Hu, Zhongliang ^a   Rahman, Mohammad Aminur ^a   Nannapaneni, Sreenivas ^a   Koenig, Lydia ^a   Chen, Zhengjia ^a   Tighiouart, Mourad ^a   Shin, Dong M ^a   Chen, Zhuo G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; GELATINASE A; MATRIX METALLOPROTEINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOKING; ZYMOGRAPHY;

EID: 84865786923     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-20-3175     Document Type: Erratum

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Globe cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005;55:74-108.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M. Cancer Statistics, 2010. CA Cancer J Clin 2009;60:277-300.
4. Bacac M, Stamenkovic I. Metastatic cancer cell. Annu Rev Pathol Mech Dis 2008;3:221-47.
5. Weinberg RA. The biology of cancer. New York: Garland Science; 2007.
6. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-58.
7. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
8. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003;20:203-13.
9. Goodfellow PJ, Nevanlinna HA, Gorman P, Sheer D, Lam G, Good-fellow PN. Assignment of the gene encoding the beta-subunit of the human fibronectin receptor (beta-FNR) to chromosome 10p11.2. Ann Hum Genet 1989;53:15-22.
10. Zhang X, Su L, Pirani AA, Wu H, Zhang H, Shin DM, et al. Understanding metastatic HNSCC cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis 2006;23:209-22.
11. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K, et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002;95:1663-72.
12. Taverna D, Ullman-Cullere M, Rayburn H, Bronson RT, Hynes RO. A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis. Cancer Res 1998;58:848-53.
13. VanWaes C, Surh DM, Chen Z, Kirby M, Rhim J, Brager R, et al. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased peoliferatin occurring with immortalization and tumor progression. Cancer Res 1995;55:5434-44.
14. Koivisto L, Grenman R, Heino J, Larjava H. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Exp Cell Res 2000;255:10-7.
15. Chirco R, Liu XW, Jung KK, Kim HR. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 2006;25:99-113.
16. Munshi HG, Stack MS. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 2006;25:45-56.
17. Maity G, Fahreen S, Banerji A, Roy Choudhury P, Sen T, Dutta A, et al. Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol Cell Biochem 2010;336:65-74
18. Li P, Zhao ZJ, Liu FY, Sun LY, Ding X, Zhang WZ, et al. The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 2010;24:989-95.
19. Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, et al. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 2008;113:97-107.
20. Klabfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons; 1980.
21. Cox DR. Regression models and life tables. J R Stat Soc Ser 1972;34:187-220.
22. Kim KH, Cho YS, Park JM, Yoon SO, Kim KW, Chung AS. Pro-MMP-2 activation by the PPARg agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK. FEBS Lett 2007;581:3303-10.
23. Morgunova E, Tuuttila A, Bergmann U, Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase. Proc Natl Acad Sci U S A 2002;99:7414-9.
24. Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001;28:261-5.
25. Köhrmann A, Kammerer U, Kapp M, Dietl J, Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 2009;9:188.
26. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. TIMP-2 promotes activation of progelatinase a by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. Nature 1994;370:61-5.
27. Sato H, Takino T, Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci 2005;96:212-7.
28. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 2010;222:268-77.
29. Alphonso A, Alahari SK. Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia 2009;11:1264-71.
30. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9-22.
31. Danen EH, Sonnenberg A. Integrins in regulation of tissue development and function. J Pathol 2003;201:632-41.
32. Wennerberg K, Lohikangas L, Gullberg D, Pfaff M, Johansson S, Fassler R. Beta 1 integrin-dependent and -independent polymerization of fibronectin. J Cell Biol 1996;132:227-38.
33. Wu C, Bauer JS, Juliano RL, McDonald JA. The alpha 5 beta 1integrin fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem 1993;268:21883-8.
34. Yang JT, Hynes RO. Fibronectin receptor functions in embryonic cells deficient in α5β1 integrin can be replaced by αV integrins. Mol Biol Cell 1996;7:1737-48.
35. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 2008;68:2329-39.
36. Siqueira AS, Gama-de-Souza LN, Arnaud MV, Pinheiro JJ, Jaeger RG. Laminin-derived peptide AG73regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin. Tumor Biol 2010;31:46-58.
37. Klein JD, Grandis JR. The molecular pathogenesis of head and neck cancer. Cancer Biol Ther 2010;9:1-7.
38. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
39. Strand DW, Franco OE, Basanta D, Anderson AR, Hayward SW. Perspectives on tissue interactions in development and disease. Cur Mol Med 2009;10:95-112.